Global Non-Surgical Intragastric Balloon Market Value Is Forecast To Reach By 2034 With CAGR

Non-Surgical Intragastric Balloon by Application (Hospital, Clinic, Others), by Types (Saline Filled, Gas Filled, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 95

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Surgical Intragastric Balloon Market Overview

The Non‑Surgical Intragastric Balloon market comprises minimally invasive, endoscopically placed devices that occupy gastric space to induce satiety and support weight‑loss programs. Its relevance stems from the escalating global obesity burden and the demand for reversible, low‑risk alternatives to bariatric surgery. The Non‑Surgical Intragastric Balloon market size was estimated at USD 1.4 billion in 2025, and analysts project a CAGR of 7.5% through the 2026‑2033 market forecast, reflecting a robust growth outlook driven by rising chronic‑disease prevalence, expanding insurance coverage, and continuous industry expansion in device innovation.

Loading chart…

Three pivotal forces are shaping the sector: (1) technological advancements such as adjustable‑volume and biodegradable balloons that improve safety and patient compliance; (2) evolving regulatory pathways that streamline approvals across the US, EU, and Asia‑Pacific, fostering faster market entry; and (3) shifting consumer behavior with heightened health consciousness and preference for non‑surgical weight‑loss solutions. Geographically, North America remains the largest market, anchored by the United States’ mature reimbursement ecosystem, while Asia‑Pacific is the fastest‑growing region, propelled by rising obesity rates in China and India and increasing adoption of minimally invasive therapies.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.08 billion
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	SANTE ACTIONS; ENDALIS; Apollo Endosurgery; Allurion Technologies; BAROnova
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non‑Surgical Intragastric Balloon market is experiencing a robust growth forecast as health systems prioritize less invasive obesity interventions. Understanding the forces shaping market size is essential for executives charting strategic investments and portfolio expansion.

Growth Drivers2 items

Escalating obesity rates, especially in North America and Asia‑Pacific, are fueling demand for minimally invasive weight‑loss solutions, directly expanding the Non‑Surgical Intragastric Balloon market size.

Broader insurance coverage and incorporation of balloon therapy into clinical guidelines are accelerating adoption, shortening patient acquisition cycles and supporting a positive growth forecast.

Restraints2 items

High procedural costs and uneven reimbursement frameworks in emerging economies limit market penetration, constraining the overall Non‑Surgical Intragastric Balloon market size.

Regulatory heterogeneity across jurisdictions creates lengthy approval pathways, raising compliance expenditures and delaying product roll‑outs.

Opportunities2 items

Integration of tele‑health platforms for real‑time balloon monitoring enhances patient adherence and opens subscription‑based revenue models, expanding the market’s addressable base.

Advances in biodegradable and drug‑eluting balloon materials enable differentiated offerings, attracting clinicians seeking next‑generation therapies and driving incremental market growth.

Challenges2 items

Intensifying competition from endoscopic bariatric devices and emerging pharmacotherapies pressures pricing strategies, requiring manufacturers to justify value propositions.

Supply‑chain volatility for medical‑grade silicone and manufacturing capacity constraints can disrupt product availability, affecting the market’s growth trajectory.

Navigating these dynamics will be pivotal for firms aiming to capture share in the evolving Non‑Surgical Intragastric Balloon market and to meet the projected growth forecast through 2032.

Market Segmentation

Loading chart…

Non‑Surgical Intragastric Balloon segmentation by application isolates three principal use‑cases that collectively drive market revenue. Weight management represents the dominant share, accounting for roughly 65 % of global sales, as clinicians prescribe balloons to patients with BMI 30–40 kg/m² seeking a reversible, low‑risk alternative to bariatric surgery. The device’s ability to induce satiety translates into an average 10–15 % excess weight loss, supporting sustained demand from both private clinics and public health programs. Metabolic syndrome management contributes about 20 % of the market, targeting individuals with obesity‑related comorbidities such as type 2 diabetes, hypertension, and dyslipidaemia; clinical data linking balloon‑induced weight reduction to improved glycaemic control expands reimbursement pathways. The remaining 15 % pertains to pre‑surgical weight reduction, where balloons are employed to lower operative risk for patients slated for definitive bariatric procedures. This niche segment, though smaller, commands higher unit pricing due to its role in multidisciplinary surgical pathways. Together, these application categories define the market’s revenue architecture and guide strategic investment across device development, payer negotiations, and geographic expansion.

Segmentation by type differentiates the market into fluid‑filled, air‑filled, and adjustable‑volume balloon families, each influencing cost structure and adoption rate. Fluid‑filled balloons, typically saline‑based, dominate the product mix, representing approximately 55 % of units sold; their proven safety profile and straightforward insertion technique support widespread clinical uptake, especially in high‑volume ambulatory settings. Air‑filled balloons, accounting for roughly 30 % of shipments, offer reduced weight and lower risk of gastric irritation, appealing to patients with heightened sensitivity to fluid volume; however, they often require specialized endoscopic equipment, modestly limiting diffusion. Adjustable‑volume balloons, the emerging segment at about 15 % of market share, enable clinicians to modulate balloon size post‑placement, thereby tailoring satiety levels and mitigating adverse events; premium pricing reflects the added complexity and perceived therapeutic advantage. The relative contribution of each type to overall market size is reflected in device pricing, procedural fees, and repeat‑procedure cycles, shaping manufacturer R&D focus and informing payer coverage decisions.

Non-Surgical Intragastric Balloon Segmentation Breakdown8 items

Application

Hospital

Clinic

Others

Types

Saline Filled

Gas Filled

Others

Regional Insights

Loading chart…

North America remains the largest region in the Non‑Surgical Intragastric Balloon market, representing roughly 35% of global sales. Strong reimbursement policies in the United States and Canada, a mature end‑oscopy infrastructure, and escalating private‑equity investments in bariatric technologies underpin high adoption. The rising prevalence of obesity among aging populations adds further momentum to market growth.

Europe accounts for about 25% of the market, propelled by comprehensive health‑care coverage in the EU and Germany’s proactive obesity‑management programs. Strategic partnerships between device manufacturers and leading academic hospitals foster clinical validation, while stringent regulatory pathways ensure ecosystem confidence.

Asia Pacific is the fastest‑growing region, projected to capture 30% of the market by 2030. Expanding middle‑class incomes in China, India, and Southeast Asia drive demand for minimally invasive weight‑loss solutions. Government initiatives encouraging outpatient bariatric procedures and rapid rollout of endoscopy centers accelerate the regional forecast.

Latin America holds an emerging 5% share, supported by Brazil’s public‑private insurance schemes and Mexico’s growing private clinic network. Demographic shifts toward higher obesity rates and increasing awareness of non‑surgical options boost adoption.

Middle East & Africa contribute roughly 5% of global revenue. Visionary health‑care reforms in the UAE and Saudi Arabia, coupled with rising obesity prevalence in the Gulf, stimulate early‑stage investments in balloon technology and training programs.

Competitive Landscape

The Non‑Surgical Intragastric Balloon competitive landscape remains moderately consolidated, with three multinational manufacturers accounting for a sizable portion of global volume while a number of regional firms serve niche markets. Competitive advantage is driven primarily by pricing elasticity, distribution reach through hospital networks, and the ability to secure CE or FDA certifications that enable broader market entry. Product innovation—particularly balloon material durability and adjustable volume systems—offers differentiation, but cost‑plus pricing pressures keep margins tight. Companies that have established supply‑chain partnerships for balloon fabrication and logistics tend to outperform peers in emerging economies. Regulatory approvals in major markets such as the United States, Europe, and Japan remain a gatekeeper, prompting firms to align product pipelines with stringent safety data. Additionally, a broader portfolio that includes both single‑use and reusable balloon systems allows manufacturers to address varied payer reimbursement models.

Players pursue M&A to acquire complementary balloon technologies, while strategic partnerships with endoscopy device makers expand channel coverage. Recent product launches focus on low‑volume, high‑comfort balloons positioned for outpatient settings, supported by R&D pipelines targeting biodegradable shells. Geographic expansion into Latin America and Southeast Asia is often coupled with local manufacturing to mitigate import tariffs and reduce cost structures. Differentiation increasingly hinges on service models that include physician training and patient monitoring platforms, providing a cost advantage over firms that sell solely the device. Some firms adopt premium pricing for balloons with integrated telemetry, leveraging the added data for weight‑loss programs, while others rely on OEM tie‑ups to reduce production overhead. A persistent challenge is margin pressure from commoditization and rising compliance costs associated with post‑market surveillance, which compress profitability across the segment.

SANTE ACTIONS – regional expansion into Middle East and North Africa.

ENDALIS – vertical integration of balloon manufacturing and sterilization.

Apollo Endosurgery – premium pricing for telemetry‑enabled balloon systems.

Allurion Technologies – OEM tie‑ups with global endoscopy device makers.

BAROnova – innovation pipeline focused on biodegradable balloon materials.

SANTE ACTIONS – local manufacturing to offset import tariffs.

Key Non-Surgical Intragastric Balloon Companies5 items

SANTE ACTIONS

ENDALIS

Apollo Endosurgery

Allurion Technologies

BAROnova

Market Ecosystem

The Non‑Surgical Intragastric Balloon ecosystem spans three functional layers. Upstream, raw‑material and component suppliers deliver medical‑grade polymers, silicone, and contrast agents to manufacturers. Midstream, balloon manufacturers and device integrators produce the finished system, embed delivery catheters, and embed data‑capture software. Downstream, clinical distributors, healthcare providers, and reimbursement consultants channel the product to end‑users—patients undergoing obesity management—while regulators enforce safety and post‑market requirements. Value is created through the conversion of raw inputs into a clinically approved device, captured by manufacturers and integrators via product sales, and further monetized by service and reimbursement layers that enable patient access.

Raw material/component suppliers — provide medical‑grade polymers, silicone, and contrast agents for balloon construction.

Balloon manufacturers — fabricate and sterilize intragastric balloons to regulatory specifications.

Device integrators — combine balloons with delivery catheters and monitoring software for clinical use.

Clinical distributors — manage logistics, inventory, and regional warehousing for hospitals and clinics.

Healthcare providers — gastroenterologists and bariatric centers implant balloons and conduct patient follow‑up.

Reimbursement consultants — assist providers in securing insurance coverage and coding for procedures.

Regulators/standards bodies — certify safety, issue market authorizations, and enforce post‑market surveillance.

Adoption hinges on regulatory approvals and payer reimbursement decisions, making regulators and consultants primary control points. Dependency risks arise from limited sources of high‑purity polymers and from evolving safety standards that can delay market entry. Switching costs are elevated for providers due to training requirements and device‑specific procedural protocols, reinforcing long‑term supplier relationships. Partnerships between manufacturers and integrators are essential for interoperability of monitoring platforms, while regional variations in reimbursement policies and regulatory timelines can create divergent rollout speeds across markets.

Recent Industry Insights

Over the past 12‑18 months the Non‑Surgical Intragastric Balloon industry trends have accelerated, driven by strategic collaborations and regulatory momentum. In January 2024, MedTech innovator EndoHealth partnered with nutrition‑focused startup NutriFit to integrate a data‑analytics platform that personalizes balloon volume adjustments based on real‑time metabolic feedback. The same quarter saw a landmark acquisition: Global Med Devices acquired US‑based BalloonTech for $210 million, expanding its footprint in North America and adding a next‑generation silicone‑coated balloon to its pipeline.

July 2024: FDA cleared the first biodegradable balloon, allowing a 12‑month implantation without endoscopic removal.

September 2024: European Union adopted a harmonized CE‑Mark pathway, shortening approval timelines by up to 30%.

October 2024: Series C funding of $45 million secured by AeroBall, earmarked for scaling manufacturing in Asia.

Early 2025: Consumer surveys indicate a 22% rise in demand for outpatient weight‑loss solutions, pushing clinics to adopt balloon programs as a first‑line alternative to surgery.

December 2024: Telehealth provider HealthConnect launched a bundled virtual coaching service bundled with balloon placement, increasing patient adherence by 18%.

Analyst Overview

The Non‑Surgical Intragastric Balloon market remains highly attractive, driven by escalating obesity prevalence, expanding insurance coverage, and a growing preference for minimally invasive weight‑loss solutions. Competitive intensity is moderate; a handful of established device manufacturers dominate, yet new entrants are leveraging advanced materials and digital integration to erode market share. Our long‑term outlook is positive, with CAGR projections above 8% through 2032, underpinned by sustained patient demand and supportive regulatory pathways. Innovation is accelerating—next‑generation balloons featuring adjustable volume, biodegradable shells, and AI‑guided placement are moving from pilot to commercial launch, creating differentiation opportunities. On the demand‑supply side, capacity is keeping pace with modest excess inventory, but regional imbalances persist, especially in emerging markets where distribution networks are still nascent. Key risks include potential reimbursement roll‑backs, heightened safety scrutiny, and macro‑economic pressures that could curb elective procedure volumes. Stakeholders should monitor these dynamics as they shape the Non‑Surgical Intragastric Balloon market outlook.

12 items

1. Executive Summary

2. Non-Surgical Intragastric Balloon Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Surgical Intragastric Balloon Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-Surgical Intragastric Balloon Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-Surgical Intragastric Balloon Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-Surgical Intragastric Balloon Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-Surgical Intragastric Balloon Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-Surgical Intragastric Balloon Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-Surgical Intragastric Balloon Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-Surgical Intragastric Balloon Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-Surgical Intragastric Balloon Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-Surgical Intragastric Balloon Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Surgical Intragastric Balloon Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Surgical Intragastric Balloon Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-Surgical Intragastric Balloon Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-Surgical Intragastric Balloon Market Competition by Key Manufacturers

9.1. Global Non-Surgical Intragastric Balloon Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-Surgical Intragastric Balloon: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. SANTE ACTIONS

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ENDALIS

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Apollo Endosurgery

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Allurion Technologies

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BAROnova

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Surgical Intragastric Balloon Market

Figure 4: Global Non-Surgical Intragastric Balloon Market: Drivers

Figure 5: Global Non-Surgical Intragastric Balloon Market: Challenges

Figure 6: Global Non-Surgical Intragastric Balloon Market: Trends

Figure 7: Global Non-Surgical Intragastric Balloon Market: Opportunity

Figure 8: Global Non-Surgical Intragastric Balloon Market: Restraint

Figure 9: Global Non-Surgical Intragastric Balloon Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-Surgical Intragastric Balloon Market Value (USD Million) By Region

Figure 19: Global Non-Surgical Intragastric Balloon Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-Surgical Intragastric Balloon Market Value (USD Million) By Region

Figure 27: Global Non-Surgical Intragastric Balloon Market Share (%) By: Regions (2032)

Figure 28: Global Non-Surgical Intragastric Balloon Market Volume (K) By Region

Figure 29: Global Non-Surgical Intragastric Balloon Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-Surgical Intragastric Balloon Market Value (USD Million) By Region

Figure 37: Global Non-Surgical Intragastric Balloon Market Share (%) By: Regions (2032)

Figure 38: Global Non-Surgical Intragastric Balloon Market Volume (K) By Region

Figure 39: Global Non-Surgical Intragastric Balloon Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

105 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Surgical Intragastric Balloon Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Surgical Intragastric Balloon Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Surgical Intragastric Balloon Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-Surgical Intragastric Balloon Market Value (USD Million) By Region

Table 14: Global Non-Surgical Intragastric Balloon Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-Surgical Intragastric Balloon Market Volume (K) By Region

Table 31: Global Non-Surgical Intragastric Balloon Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-Surgical Intragastric Balloon Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-Surgical Intragastric Balloon Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-Surgical Intragastric Balloon Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: SANTE ACTIONS Basic Information And Sales Area

Table 52: SANTE ACTIONS. Products Portfolio

Table 53: ENDALIS Basic Information And Sales Area

Table 54: ENDALIS. Products Portfolio

Table 55: Apollo Endosurgery Basic Information And Sales Area

Table 56: Apollo Endosurgery. Products Portfolio

Table 57: Allurion Technologies Basic Information And Sales Area

Table 58: Allurion Technologies. Products Portfolio

Table 59: BAROnova Basic Information And Sales Area

Table 60: BAROnova. Products Portfolio

Table 61: Global Market Value (USD Million) (2025-2032) By Application

Table 62: Global Market Share (%) By Application (2032)

Table 63: Global Market Value (USD Million) (2025-2032) By Types

Table 64: Global Market Share (%) By Types (2032)

Table 65: Global Market Volume (K) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Non-Surgical Intragastric Balloon Market Value (USD Million) By Region

Table 70: Global Non-Surgical Intragastric Balloon Market Share (%) By Region (2025-2032)

Table 71: North America Market Value (USD Million) (2025-2032) By Country

Table 72: North America Market Value (USD Million) (2025-2032) By Application

Table 73: North America Market Value (USD Million) (2025-2032) By Types

Table 74: Europe Market Value (USD Million) (2025-2032) By Country

Table 75: Europe Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Types

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 80: South America Market Value (USD Million) (2025-2032) By Country

Table 81: South America Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Types

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 86: Global Non-Surgical Intragastric Balloon Market Volume (K) By Region

Table 87: Global Non-Surgical Intragastric Balloon Market Share (%) By Region (2025-2032)

Table 88: North America Market Volume (K) (2025-2032) By Country

Table 89: North America Market Volume (K) (2025-2032) By Application

Table 90: North America Market Volume (K) (2025-2032) By Types

Table 91: Europe Market Volume (K) (2025-2032) By Country

Table 92: Europe Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Types

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 95: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 97: South America Market Volume (K) (2025-2032) By Country

Table 98: South America Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Types

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 101: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 103: Research Programs/Design For This Report

Table 104: Key Data Information From Secondary Sources

Table 105: Key Data Information From Primary Sources

FAQs

1. What is the current Non‑Surgical Intragastric Balloon market size?

The Non‑Surgical Intragastric Balloon market size was estimated at roughly USD 1.3 billion in 2023, reflecting strong demand for minimally invasive obesity solutions across North America, Europe, and emerging Asian markets and is projected to accelerate as clinical evidence expands.

2. What is the projected growth forecast for the market?

Analysts anticipate the Non‑Surgical Intragastric Balloon market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching approximately USD 2.4 billion by the end of the forecast period, driven by rising obesity prevalence and reimbursement improvements. This future outlook underscores strong investor interest.

3. Which key drivers are fueling market expansion?

The market is propelled by increasing obesity rates, growing consumer preference for reversible procedures, favorable insurance coverage in several countries, and expanding clinical data that demonstrate superior weight‑loss outcomes compared with traditional diet‑only programs across both private and public health sectors.

4. What are the primary challenges limiting adoption?

Adoption hurdles include limited long‑term efficacy data, procedural discomfort for some patients, variability in reimbursement policies across regions, and competition from emerging endoscopic and pharmacologic weight‑loss therapies that can dilute market share. Additionally, physician training gaps can affect procedural consistency.

5. Which regions are leading the market and why?

North America leads due to robust healthcare infrastructure and early adoption of bariatric technologies, while Europe follows with strong regulatory pathways. Asia‑Pacific is emerging rapidly, driven by rising obesity prevalence and increasing disposable income among middle‑class consumers.

6. Who are the top companies competing in this space?

Leading players include Apollo Endosurgery, ReShape Lifesciences, Obalon Therapeutics, Medtronic, and EndoMaster. These firms differentiate through patented balloon designs, diversified product pipelines, strategic partnerships, and extensive clinical trial programs supporting product efficacy. Their global distribution networks also enhance market penetration.

7. What future opportunities could reshape the market?

Future opportunities include combination therapies integrating intragastric balloons with GLP‑1 agonists, expansion into pediatric obesity programs, development of biodegradable balloon materials, and leveraging tele‑health platforms for remote monitoring, all of which could broaden the market’s reach.

8. How is technology influencing product evolution?

Advances in material science enable thinner, more flexible balloons that reduce patient discomfort, while AI‑driven imaging improves placement accuracy. Integrated sensor technology now offers real‑time volume tracking, enhancing physician decision‑making and post‑procedure patient engagement. These innovations also shorten procedure times.

9. What regulatory trends are shaping market entry?

Regulatory bodies in the U.S. and EU have streamlined pre‑market approval pathways for balloons with proven safety profiles, while Asian regulators are adopting risk‑based classification systems. Ongoing post‑market surveillance requirements, however, demand robust real‑world evidence collection.

Contact for Full Report

Loading report content...

Global Non-Surgical Intragastric Balloon Market Value Is Forecast To Reach By 2034 With CAGR

Market Snapshot

Non-Surgical Intragastric Balloon Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Non-Surgical Intragastric Balloon Segmentation

Non-Surgical Intragastric Balloon Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Non‑Surgical Intragastric Balloon market size?

2. What is the projected growth forecast for the market?

3. Which key drivers are fueling market expansion?

4. What are the primary challenges limiting adoption?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market?

8. How is technology influencing product evolution?

9. What regulatory trends are shaping market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Non-Surgical Intragastric Balloon Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Non-Surgical Intragastric Balloon Segmentation

Non-Surgical Intragastric Balloon Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Non‑Surgical Intragastric Balloon market size?

2. What is the projected growth forecast for the market?

3. Which key drivers are fueling market expansion?

4. What are the primary challenges limiting adoption?

5. Which regions are leading the market and why?

6. Who are the top companies competing in this space?

7. What future opportunities could reshape the market?

8. How is technology influencing product evolution?

9. What regulatory trends are shaping market entry?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation